WePeptideRx review

WePeptideRx earns genuine credit for transparency: it publishes an actual per-dose price ladder, tier by tier, for both molecules and for both monthly and ninety-day programs, all before any intake — which almost nobody else here does. A licensed provider is seen by video inside a day, shipping is included, and if you are not approved the money comes back as money rather than store credit. Then the arithmetic turns. Its named microdose line is flat at any strength, and that flat figure sits above the bottom rung of its own standard ladder for both molecules. So on this site's only real question — does taking less cost less — the answer here is no, it costs more, and the provider's own published numbers are what prove it. That is a finding, not a quibble.

Vs median

$30/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

WePeptideRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

One of the very few operators here that publishes a genuine per-dose price ladder: six tirzepatide tiers from 2.5 mg/wk up to 15 mg/wk, each with its own 30-day figure, plus 90-day programs, all before intake. A licensed U.S. provider is seen by video inside 24 hours and the money is fully refunded — not credited — if you are not approved. It also sells a named microdose line, flat at any strength, bundled with B12 and glycine. And that is where the arithmetic turns against the reader this site is written for: the microdose costs more per month than simply starting on the bottom rung of the standard ladder.

Its microdose costs MORE than its own starting standard dose — flat $199 for microdose semaglutide against $189 for the 2.5 mg/wk first rung, and $229 against $199 on tirzepatide — so deliberately taking less is billed at a premium here, the opposite of what a low-dose reader wants

• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
• The microdose line is injectable only, with no oral or sublingual route published
• The compounding pharmacy is described only as a licensed U.S. pharmacy and is never named
• The catalog runs well beyond metabolic care into hair, hormone and sexual-wellness lines, which is a breadth-over-depth signal

WePeptideRx is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• Titrating up from a microdose
• Microdose & reconstitution calculator
• Titration planner